✦ LIBER ✦

C.04.02 What can we do to improve adherence to treatment in patients with schizophrenia?

✍ Scribed by Cañas, F.

Book ID: 121901849
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 55 KB
Volume: 23
Category: Article
ISSN: 0924-977X
DOI: 10.1016/S0924-977X(13)71006-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

C.09.01 How can we help our patients wit

C.09.01 How can we help our patients with schizophrenia adhere to their medication?

✍ R. Emsley 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 54 KB

Meeting breast cancer patients' informat

Meeting breast cancer patients' information needs during radiotherapy: what can we do to improve the information and support that is currently provided?

✍ G.K.B. HALKETT; L.J. KRISTJANSON; E. LOBB; C. O'DRISCOLL; M. TAYLOR; N. SPRY 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 120 KB

P-1273 - Short message service to improv

P-1273 - Short message service to improve treatment adherence and quality of life in patients with schizophrenia in spain: the SMS study

✍ Montes, J.M.; Maurino, J.; Medina, E. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 French ⚖ 66 KB

P1180 CAN A LIFESTYLE MODIFICATION INTER

P1180 CAN A LIFESTYLE MODIFICATION INTERVENTION IMPROVE RISK FACTORS FOR A NEGATIVE RESPONSE TO PEGINTERFERON TREATMENT IN PATIENTS WITH CHRONIC HEPATITIS C, CIRRHOSIS AND OBESITY?

✍ Agarwal, A.; Pattullo, V.; Garcia-Saenz-de-Sicilia, M.; Sockalingam, S.; Fantus, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Could HTR2A T102C and DRD3 Ser9Gly predi

Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting

✍ Byungsu Kim; Eui Yul Choi; Chang Yoon Kim; Kyuyung Song; Yeon Ho Joo 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

## Abstract ## Objective This study seeks to replicate previous results indicating that T102C in the serotonin 2A receptor (HTR2A) and Ser9Gly in the dopamine D3 receptor (DRD3) were associated with a risperidone response to acutely exacerbated schizophrenia, and to determine whether possession of